{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T08:40:55Z","timestamp":1648975255014},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,9,1]],"date-time":"2003-09-01T00:00:00Z","timestamp":1062374400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2003,9]]},"DOI":"10.1007\/s12022-003-0018-y","type":"journal-article","created":{"date-parts":[[2007,5,14]],"date-time":"2007-05-14T13:00:04Z","timestamp":1179147604000},"page":"257-262","source":"Crossref","is-referenced-by-count":1,"title":["Immunohistochemical evaluation of vasopressin expresion in breast fibrocystic disease and ductal carcinoma In situ (DCIS)"],"prefix":"10.1007","volume":"14","author":[{"given":"William G.","family":"North","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Wells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Fay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rennie S.","family":"Mathew","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Donnelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent A.","family":"Memoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"18_CR1","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/1097-0142(19930315)71:6+<2127::AID-CNCR2820711602>3.0.CO;2-2","volume":"71","author":"IC Henderson","year":"1993","unstructured":"Henderson IC. Risk factors for breast cancer development. Cancer 71:2127\u20132140, 1993.","journal-title":"Cancer"},{"key":"18_CR2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1677\/erc.0.0080047","volume":"8","author":"DC Allred","year":"2001","unstructured":"Allred, DC, Mohsin, SK, Fuqua, SA. Histological and biological evolution of human premalignant breast disease. Endocr Relat Cancer 8:47\u201361, 2001.","journal-title":"Endocr Relat Cancer"},{"key":"18_CR3","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/1097-0142(19930215)71:4<1187::AID-CNCR2820710402>3.0.CO;2-V","volume":"71","author":"JL Connolly","year":"1993","unstructured":"Connolly JL, Schnitt SJ. Benign breast disease resolved and unresolved issues. Cancer 71:1187\u20131189, 1993.","journal-title":"Cancer"},{"key":"18_CR4","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJM198501173120303","volume":"312","author":"WD Dupont","year":"1985","unstructured":"Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146\u2013151, 1985.","journal-title":"N Engl J Med"},{"key":"18_CR5","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/1097-0142(19930215)71:4<1258::AID-CNCR2820710415>3.0.CO;2-I","volume":"71","author":"WD Dupont","year":"1993","unstructured":"Dupont WD, Parl FF, Hartmann WH, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer 71:1258\u20131265, 1993.","journal-title":"Cancer"},{"key":"18_CR6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1001\/jama.1992.03480070057030","volume":"267","author":"SJ London","year":"1992","unstructured":"London SJ, Connolly JL, Schnitt SJ, Colditz GA. A prospective study of benign breast disease and the risk of breast cancer. JAMA 267:941\u2013944, 1992.","journal-title":"JAMA"},{"key":"18_CR7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1023\/A:1026439204849","volume":"5","author":"E Mallon","year":"2000","unstructured":"Mallon E, Osin P, Nasiri N, Blain I, Howard B, Gusterson B. The basic pathology of breast cancer. J Mammary Gland Biol Neoplasia 5:139\u2013163, 2000.","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"18_CR8","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/bcr306","volume":"3","author":"M Bai","year":"2001","unstructured":"Bai M, Agnantis NJ, Kamina S, et al. In vivo cell kinetic in breast carcinogenesis. Breast Cancer Res 3:276\u2013283, 2001.","journal-title":"Breast Cancer Res"},{"key":"18_CR9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF00689714","volume":"34","author":"WG North","year":"1995","unstructured":"North WG, Pai S, Friedmann A, Yu X, Fay M, Memoli V. Vasopressin gene related products are markers of human breast cancer. Breast Cancer Res Treatment 34:229\u2013235, 1995.","journal-title":"Breast Cancer Res Treatment"},{"key":"18_CR10","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/bjc.1994.49","volume":"69","author":"AS Friedmann","year":"1994","unstructured":"Friedmann AS, Malott KA, Memoli VA, Pai SI, Yu X, North WG. Products of vasopressin gene expression in small-cell carcinoma of the lung. Br J Cancer 69:260\u2013263, 1994.","journal-title":"Br J Cancer"},{"key":"18_CR11","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1210\/jcem-73-6-1316","volume":"73","author":"WG North","year":"1991","unstructured":"North WG. Neuropeptide production by small cell carcinoma: vasopressin and oxytocin as plasma markers of disease. J Clin Endocrinol Metab 73:1316\u20131320, 1991.","journal-title":"J Clin Endocrinol Metab"},{"key":"18_CR12","first-page":"311","volume":"48","author":"WJ Waddel","year":"1956","unstructured":"Waddel WJ. A simple ultraviolet spectrophotometric method for the determination of protein. J Lab Clin Med 48:311\u2013314, 1956.","journal-title":"J Lab Clin Med"},{"key":"18_CR13","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/27.8.90074","volume":"27","author":"JL Guesdon","year":"1979","unstructured":"Guesdon JL, Ternynck T, Avaremeas S. The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 27:1131\u20131139, 1979.","journal-title":"J Histochem Cytochem"},{"key":"18_CR14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/20.10.829","volume":"20","author":"JG Streefkerk","year":"1972","unstructured":"Streefkerk JG. Inhibition of erythrocyte pseudoperoxidase activity by treatment with hydrogen peroxide following methanol. J Histochem Cytochem 20:829\u2013831, 1972.","journal-title":"J Histochem Cytochem"},{"key":"18_CR15","first-page":"441","volume":"34","author":"A. Gupta","year":"1986","unstructured":"Gupta, A., Sasarula S, Rao PV. The syndrome of inappropriate secretion of antidiuretic hormone in a case of carcinoma of the breast. J Assoc Physicians India 34:441\u2013442, 1986.","journal-title":"J Assoc Physicians India"},{"key":"18_CR16","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1016\/0959-8049(93)90237-A","volume":"29A","author":"AC Howard","year":"1993","unstructured":"Howard AC, Laing RW, Hussain FN. Breast carcinoma presenting with inappropriate ADH secretion. Eur J Cancer 29A:2339, 1993.","journal-title":"Eur J Cancer"},{"key":"18_CR17","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1042\/bj2400189","volume":"240","author":"G Guillon","year":"1986","unstructured":"Guillon G, Kirk CJ, Balestre M. Characterization of specific V1a vasopressin-binding sites on a rat mammary-tumor-cell line. Biochem J 240:189\u2013196, 1986.","journal-title":"Biochem J"},{"key":"18_CR18","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1042\/bj2400197","volume":"240","author":"CJ Kirk","year":"1986","unstructured":"Kirk CJ, Guillon G, Balestre M, Jard S. Stimulation, by vasopressin and other agonists, of inositol-lipid breakdown and inositol phosphate accumulation in WRK1 cells. Biochem J 240:197\u2013204, 1986.","journal-title":"Biochem J"},{"key":"18_CR19","first-page":"4101","volume":"38","author":"ME Monaco","year":"1978","unstructured":"Monaco ME, Lippman ME, Knazek R, Kidwell WR. Vasopressin stimulation of acetate incorporation into lipids in a dimethylbenz(a)anthracene-induced rat mammary tumor induced cell line. Cancer Res 38:4101\u20134104, 1978.","journal-title":"Cancer Res"},{"key":"18_CR20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1042\/bj1880437","volume":"188","author":"ME Monaco","year":"1980","unstructured":"Monaco ME, Kidwell WR, Lippman ME. Neurohypophysial-hormone-responsive cell line derived from a dimethylbenzanthraceneinduced rat mammary tumor. Biochem J 188:437\u2013441, 1980.","journal-title":"Biochem J"},{"key":"18_CR21","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1210\/mend-2-4-350","volume":"2","author":"DJ Woods","year":"1988","unstructured":"Woods DJ, Monaco ME. Characterization of the vasopressin receptor on WRK-1 cells. Mol Endocrinol 2:350\u2013354, 1988.","journal-title":"Mol Endocrinol"},{"key":"18_CR22","first-page":"7882","volume":"50","author":"AH Taylor","year":"1990","unstructured":"Taylor AH, Ang VTY, Jenkins JS, Silverlight JJ, Coombes RC, Luqmani YA. Interaction of vasopressin and oxytocin with human breast carcinoma cells. Cancer Res 50:7882\u20137886, 1990.","journal-title":"Cancer Res"},{"key":"18_CR23","first-page":"145","volume":"13","author":"PA Bunn","year":"1992","unstructured":"Bunn PA, Dienhart DG, Chan D, Tagawa M, Jewett P. Effects of neuropeptides on human lung and breast cancer cells. J Natl Cancer Inst Monogr 13:145\u2013151, 1992.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"18_CR24","first-page":"6434","volume":"54","author":"K Chooi","year":"1994","unstructured":"Chooi K, Carter DA, Biswas S, Lightman SL, Ho M, Murphy D. Ectopic vasopressin expression in MMTV-Wnt-1 transgenic mice modifies mammary tumor differentiation and pathology. Cancer Res 54:6434\u20136440, 1994.","journal-title":"Cancer Res"},{"key":"18_CR25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1677\/erc.0.0080033","volume":"8","author":"KA Skinner","year":"2001","unstructured":"Skinner KA, Silverstein MJ. The management of ductal carcinoma of the breast. Endocrin Relat Cancer 8:33\u201345, 2001.","journal-title":"Endocrin Relat Cancer"},{"key":"18_CR26","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s101470300001","volume":"8","author":"K Mokbel","year":"2003","unstructured":"Mokbel K. Current management of ductal carcinoma in situ of the breast. Int J Clin Oncol 8:18\u201322, 2003.","journal-title":"Int J Clin Oncol"},{"key":"18_CR27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1349-7006.2001.tb01095.x","volume":"92","author":"N Ariga","year":"2001","unstructured":"Ariga N, Suzuki T, Moriya T, et al. Progesterone receptor A and B isoforms in the human breast and its disorders. Jpn J Cancer Res 92:302\u2013308, 2001.","journal-title":"Jpn J Cancer Res"},{"key":"18_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1023\/A:1006446108411","volume":"65","author":"JS Winston","year":"2001","unstructured":"Winston JS, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB. Downregulation of gelsolin correlates with the progression to breast carcinoma. Breast Cancer Res Treat 65:11\u201321, 2001.","journal-title":"Breast Cancer Res Treat"},{"key":"18_CR29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1053\/hupa.2001.24327","volume":"32","author":"C Leal","year":"2001","unstructured":"Leal C, Henrique R, Monteiro P, et al. Apocrine ductal carcinoma in situ of the breast: histologic classification and expression of biologic markers. Human Path 32:487\u2013493, 2001.","journal-title":"Human Path"},{"key":"18_CR30","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/019131201317101216","volume":"25","author":"Z Suo","year":"2001","unstructured":"Suo Z, Bjaamer A, Ottestad L, Nesland JM. Expression of EGFR family and steroid hormone receptors in ductal carcinoma in situ of the breast. Ultrastruct Pathol 25:349\u2013356, 2001.","journal-title":"Ultrastruct Pathol"},{"key":"18_CR31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s004180100313","volume":"116","author":"B Paepe De","year":"2001","unstructured":"De Paepe B, Verstraeten VL, De Potter CR, Vakaet LA, Bullock GR. Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma. Histochem Cell Biol 116:247\u2013254, 2001.","journal-title":"Histochem Cell Biol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-003-0018-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-003-0018-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-003-0018-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T01:57:26Z","timestamp":1559440646000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-003-0018-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,9]]}},"alternative-id":["18"],"URL":"https:\/\/doi.org\/10.1007\/s12022-003-0018-y","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,9]]}}}